44 results
8-K
EX-99.1
TPST
Tempest Therapeutics, Inc.
9 May 24
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
4:25pm
.
"The positive data and mechanistic analysis presented in the first quarter build on the positive preclinical and clinical data package for TPST-1120
8-K
EX-99.1
3iuql36r077tk978zg
11 Oct 23
Entry into a Material Definitive Agreement
8:13am
S-8
sdii8 4h3
21 Jun 22
Registration of securities for employees
8:05am
S-8
f73 axsm3e
13 May 22
Registration of securities for employees
4:14pm
PRE 14A
j2rhzzaawx9kn0 kdkg
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-99.1
bnjmfpske1nxq5u 8u4
16 Jul 21
Other Events
4:31pm
8-K
EX-99.4
krevl0sdpw a9hwt6
16 Jul 21
Other Events
4:31pm
8-K/A
EX-99.1
zjk87wg56gllln9m6
1 Jul 21
Changes in Registrant's Certifying Accountant
4:44pm